Statistics on Biotechnology Use  
Results by sector of operation
Company sector. Biotechnology results by main variables and no. of employees. 
Unidades: specified in variables

,Fewer than 250 employees,250 or more employees,Total,
No. of companies carrying out R&D in Biotechnology,1.040,93,1.133,
%Companies according to biotechnology used: Genetic code,32,43,33,
%Companies according to biotechnology used: Functional units,40,51,41,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,22,41,24,
%Companies according to biotechnology used: Bioprocesses,48,69,50,
%Companies according to biotechnology used: Sub-cellular organisms,5,12,6,
%Companies according to biotechnology used: Bio-computing,24,28,24,
%Companies according to biotechnology used: Nanobiotechnology,13,13,13,
%Companies according to biotechnology used: Other,15,8,14,
Companies in which biotechnology activities are: Main and/or exclusive,581,22,603,
Companies in which biotechnology activities are: A secondary line of business,155,18,173,
Companies in which biotechnology activities are: A tool necessary for production,305,53,357,
%Company by field(s) of ultimate application of biotechnology use: Human Health,45,49,45,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,19,3,18,
%Company by field(s) of ultimate application of biotechnology use: Food products,30,39,31,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,23,17,22,
%Company by field(s) of ultimate application of biotechnology use: Environment,13,17,14,
%Company by field(s) of ultimate application of biotechnology use: Industry,13,9,12,
Personnel in R&D in biotechnology (no. of persons),8.124,3.386,11.510,
Personnel in R&D in biotechnology (no. of persons): Researchers,4.552,1.650,6.202,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,3.572,1.736,5.308,
Personnel in R&D in biotechnology (no. of persons): women,4.363,2.026,6.389,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,2.368,935,3.304,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,1.995,1.090,3.086,
Personnel in R&D in biotechnology (FTE),5.788,1,2.448,9,8.236,9,
Personnel in R&D in biotechnology (FTE): Researchers,3.364,3,1.231,9,4.596,1,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,2.423,8,1.217,3.640,8,
Personnel in R&D in biotechnology (FTE): women,3.197,5,1.501,4.698,5,
Personnel in R&D in biotechnology (FTE): (women) Researchers,1.803,7,708,8,2.512,5,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,1.393,8,792,2,2.186,
Internal expenditure on R&D (thousands of euros),558.184,211.247,769.431,
1) By nature of the expense: Current expenses,518.032,201.684,719.715,
1.1) Remuneration to researchers,154.555,66.892,221.447,
1.2) Remuneration to technicians and assistants,72.617,50.192,122.809,
1.3) Other current expenses,290.860,84.599,375.459,
2) By nature of the expense: Capital expenses,40.152,9.563,49.715,
2.1) Land and buildings,6.661,2.860,9.521,
2.2) Equipment and instruments,24.465,6.001,30.466,
2.3) Acquisition of specific R&D software,1.157,653,1.810,
2.4) Otros productos de propiedad intelectual específicos para I+D,7.869,49,7.919,
1.1) By origin of the funds: Own funds,385.847,105.066,490.913,
1.2) By origin of the funds: From companies,53.140,29.409,82.548,
1.3) By origin of the funds: Public Administration funds,64.168,32.641,96.809,
1.4) By origin of the funds: From Universities,197,0,197,
1.5) By origin of the funds: From non profit private institutions,588,4.177,4.766,
1.6) By origin of the funds: Foreign funds,54.244,39.954,94.197,
Purchase of R&D services in biotechnology (thousands of euros),68.331,51.951,120.281,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,22.667,46.897,69.564,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,45.664,5.054,50.718,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,47,23,45,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,12,13,12,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,16,15,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,13,15,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets,17,11,16,
%Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and sales channels,19,10,18,
%Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception,16,13,15,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,37,29,37,
%Companies that consider the following obstacles as very important considering biotechnology development: Time / cost,53,39,52,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,20,14,20,
% Companies that have requested biotechnology patents in Biotechnology,15,17,15,
Number of patents requested,525,156,681,
% Companies with income of an international origin related to biotechnological activities,24,9,18,4,24,3,
% Turnover representing income of an international origin related to biotechnological activities,6,1,1,
% Income of an international origin related to biotechnological activities distributed in: Income received from the EU,45,2,73,1,59,6,
% Income of an international origin related to biotechnological activities distributed in: Income received from other countries,54,8,26,9,40,4,
% Income of an international origin related to biotechnological activities by classification: Internacional trade in products and services,89,72,5,80,4,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,7,5,24,9,16,5,
% Income of an international origin related with activities according to the classification: Operating source abroad,2,2,2,3,2,2,
% Income of an international origin related with activities according to the classification: Other,1,4,0,4,0,9,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute